Recherche
-
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
(Neurology. vol. 8, n° 4, 2021-04-26)Article de revueLibre accès -
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis
(Journal of Neurology. vol. 268, n° 2, pp. 669-679, 2021-02)Article de revue -
Structure-function coupling as a correlate and potential biomarker of cognitive impairment in multiple sclerosis
(Network Neuroscience. vol. 6, n° 2, pp. 339-356, 2022-06-01)Article de revueLibre accès -
Do isolated cognitive relapses exist? Commentary
(Multiple Sclerosis Journal. vol. 27, n° 10, pp. 1489-1490, 2021-09)Article de revueLibre accès -
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica
(Annals of Clinical and Translational Neurology. vol. 8, n° 10, pp. 2025-2037, 2021-10)Article de revueLibre accès -
Insights on the Relationship Between Hippocampal Connectivity and Memory Performances at the Early Stage of Multiple Sclerosis
(Frontiers in Neurology. vol. 12, 2021-05-19)Article de revueLibre accès -
Differential vulnerability of thalamic nuclei in multiple sclerosis
(Multiple Sclerosis Journal, 2022-08-12)Article de revueLibre accès -
Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis
(Frontiers in immunology. vol. 12, 2021-05-04)Article de revueLibre accès -
The radiologically isolated syndrome: revised diagnostic criteria
(Brain - A Journal of Neurology, 2023-03-02)Article de revue -
Comparison of Simoa™ and Ella™ to assess serum neurofilament-light chain in multiple sclerosis
(Annals of Clinical and Translational Neurology. vol. 8, n° 5, pp. 1141-1150, 2021-05)Article de revueLibre accès